Voyageur Pharmaceuticals (CVE:VM) Sets New 12-Month High – Here’s What Happened

by · The Cerbat Gem

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as C$0.11 and last traded at C$0.11, with a volume of 641138 shares trading hands. The stock had previously closed at C$0.09.

Voyageur Pharmaceuticals Stock Up 16.7 %

The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a 50 day moving average price of C$0.07 and a 200-day moving average price of C$0.06. The stock has a market capitalization of C$14.64 million, a P/E ratio of -10.50 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More